首页 | 本学科首页   官方微博 | 高级检索  
     


Choroideremia: molecular mechanisms and therapies
Affiliation:1. Development, Ageing, and Disease, University College London (UCL) Institute of Ophthalmology, London, EC1V 9EL, UK;2. Ocular Genomics and Therapeutics Laboratory, The Francis Crick Institute, London, NW1 1AT, UK;3. Department of Genetics, Moorfields Eye Hospital National Health Service (NHS) Foundation Trust, London, EC1V 2PD, UK;4. Department of Ophthalmology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, WC1N 3JH, UK;1. Vaccine & Immunotherapy Center, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02129, USA;2. Metabolism Unit, Division of Endocrinology, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, USA;3. Central Arkansas Veterans Healthcare System and Department of Geriatrics, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA;1. Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, ONT, Canada;2. Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ONT, Canada
Abstract:
Keywords:
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号